FindTrial
Sign In

Buprenorfiini-naloksoni ja metadoni erilaisissa psykososiaalisissa hoito-ohjelmissa buprenorfiiniriippuvaisten korvaushoidossa. Satunnaistettu kontrolloitu tutkimus

Buprenorfiini-naloksoni ja metadoni erilaisissa psykososiaalisissa hoito-ohjelmissa buprenorfiiniriippuvaisten korvaushoidossa. Satunnaistettu kontrolloitu tutkimus

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-012814-36-FI
Enrollment
Unknown
Registered
2009-06-22
Start date
2009-09-23
Completion date
Unknown
Last updated
2012-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioidiriippuvuus, buptenorfiinin suonensisäinen väärinkäyttö MedDRA version: 9.1 Level: LLT Classification code 10030893 Term: Opioid type dependence, continuous use

Interventions

Trade Name: Suboxone Pharmaceutical Form: CAS Number: 53152219 Other descriptive name: BUPRENORPHINE HYDROCHLORIDE Concentration unit: mg milligram(s) Concentration type: equal Concentration number:

Sponsors

Helsingin Diakonissalaitos
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026